Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.110
-0.120 (-2.84%)
At close: Nov 9, 2026, 4:00 PM EST
4.120
+0.010 (0.24%)
After-hours: Nov 9, 2026, 4:15 PM EST
Outset Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Outset Medical stock has a consensus rating of "Buy" and an average price target of $7.67. The average 1-year stock price forecast is 86.55% higher than the current stock price, while the lowest is $6.00 (+45.99%) and the highest is $10 (+143.31%).
Price Target: $7.67 (+86.55%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Outset Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $6 | Buy | Maintains | $6 | +45.99% | Nov 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $10 | Buy | Maintains | $10 | +143.31% | Nov 5, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $7 | Hold | Maintains | $7 | +70.32% | Nov 5, 2026 |
Financial Forecast
Revenue This Year
127.50M
from 119.48M
Increased by 6.72%
Revenue Next Year
139.30M
from 127.50M
Increased by 9.25%
EPS This Year
-3.07
from -4.30
EPS Next Year
-2.32
from -3.07
EPS and Forward PE are based on non-GAAP adjusted numbers.